|
[1] ZHU Q,XIANG CH. Current status regarding diagnosis and management of idiopathic portal hypertension[J]. Chin J Gen Surg,2019,28(1):117-124.(in Chinese)朱青，项灿宏．特发性门静脉高压症的诊治现状[J]．中国普通外科杂志，2019,28(1):117-124.
|
|
[2] INOKUMA T,EGUCHI S,TOMONAGA T,et al. Acute deterioration of idiopathic portal hypertension requiring living donor liver transplantation:A case report[J]. Dig Dis Sci,2009,54(7):1597-1601.
|
|
[3] LIU HB,ZHANG BJ,LYU Y,et al. Research advances in idiopathic non-cirrhotic portal hypertension[J]. J Clin Hepatol,2017,33(2):348-353.(in Chinese)刘海博，张博静，吕勇，等．特发性非肝硬化门静脉高压症的研究进展[J]．临床肝胆病杂志，2017,33(2):348-353.
|
|
[4] ZHANG BJ,HAN GH,FAN DM. Research advances in noncirrhotic portal hypertension[J]. J Clin Hepatol,2016,32(2):245-249.(in Chinese)张博静，韩国宏，樊代明．非肝硬化性门静脉高压症的研究现状[J]．临床肝胆病杂志，2016,32(2):245-249.
|
|
[5] SUN YL,XU L,CHEN S,et al. Clinical features of idiopathic portal hypertension in China:A restrospective study of 338 patients and literature review[J]. J Gastroenterol Hepatol,2019,34(8):1417-1423.
|
|
[6] SIRAMOLPIWAT S,SEIJO S,MIQUEL R,et al. Idiopathic portal hypertension:Natural history and long-term outcome[J].Hepatology,2014,59(6):2276-2285.
|
|
[7] European Association for the Study of the Liver. EASL clinical practice guidelines:Vascular diseases of the liver[J]. J Hepatol,2016,64(1):179-202.
|
|
[8] Working Subgroup for Clinical Practice Guideline for Aberrant Portal Hemodynamics. Diagnosis and treatment guidelines for aberrant portal hemodynamics:The Aberrant Portal Hemodynamics Study Group supported by the Ministry of Health,Labor and Welfare of Japan[J]. Hepatol Res,2017,47(5):373-386.
|
|
[9] MA XM,REN H,JIN B,et al. Clinical and pathological features analysis of 21 patents with idiopathic portal hypertension[J]. Infect Dis Info,2017,30(3):168-171.(in Chinese)马雪梅，任辉，金波，等．21例特发性门脉性高压临床及病理特点分析[J]．传染病信息，2017,30(3):168-171.
|
|
[10] SCHOUTEN JN,GARCIA-PAGAN JC,VALLA DC,et al. Idiopathic noncirrhotic portal hypertension[J]. Hepatology,2011,54(3):1071-1081.
|
|
[11] XU X,GUO HJ,LI WY. Treatment options for portal hypertension in the era of liver transplantation[J]. Chin J Dig Surg,2018,17(10):992-996.(in Chinese)徐骁，郭海军，李望遥．肝移植时代门静脉高压症的治疗选择[J]．中华消化外科杂志，2018,17(10):992-996.
|
|
[12] DUMORTIER J,BIZOLLON T,SCOAZEC JY,et al. Orthotopic liver transplantation for idiopathic portal hypertension:Indications and outcome[J]. Scand J Gastroenterol,2001,36(4):417-422.
|
|
[13] HERNNDEZ-GEA V,BAIGES A,TURON F,et al. Idiopathic portal hypertension[J]. Hepatology,2018,68(6):2413-2423.
|
|
[14] KOU JT,LIU Z,ZHU JQ,et al. Research on clinical efficacy of liver transplantation for severe liver disease[J]. Ogran Transplantation,2020,11(4):482-486.(in Chinese)寇建涛，刘喆，朱继巧，等．肝移植治疗危重症肝病的临床疗效研究[J]．器官移植，2020,11(4):482-486.
|
|
[15] KRASINSKAS AM,EGHTESAD B,KAMATH PS,et al. Liver transplantation for severe intrahepatic noncirrhotic portal hypertension[J]. Liver Transpl,2005,11(6):627-634.
|
DownLoad: